SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-005312
Filing Date
2023-03-31
Accepted
2023-03-31 16:45:01
Documents
15
Period of Report
2023-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmbr-20230331x8k.htm   iXBRL 8-K 35132
2 EX-99.1 tmbr-20230331xex99d1.htm EX-99.1 175480
3 GRAPHIC tmbr-20230331xex99d1001.jpg GRAPHIC 4089
  Complete submission text file 0001558370-23-005312.txt   355818

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmbr-20230331.xsd EX-101.SCH 3733
5 EX-101.DEF tmbr-20230331_def.xml EX-101.DEF 2729
6 EX-101.LAB tmbr-20230331_lab.xml EX-101.LAB 17362
7 EX-101.PRE tmbr-20230331_pre.xml EX-101.PRE 10164
9 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20230331x8k_htm.xml XML 4862
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 23788650
SIC: 2834 Pharmaceutical Preparations